Brief: RenovoRx reports Q2 results
15/08/2022 13:16
Aug 15 (Reuters) - RenovoRx Inc RNXT.O :
* RENOVORX REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS
Source text for Eikon: ID:nBw7xynqZa
Further company coverage: RNXT.O
Recent news on RenovoRx
See all newsBrief: Renovorx Advances Tamp Into Borderline Resectable Pancreatic Cancer With First Patient Enrolled In Investigator-Initiated Prism-Tamp Trial
RenovoRx Inc reports results for the quarter ended June 30 - Earnings Summary
Oncology device maker RenovoRx's Q2 revenue surges, raises FY outlook
Brief: RenovoRx Q2 Net Income USD -2.911 Million
Brief: Renovorx Achieves Major Milestone With Full Enrollment In Phase Iii Tiger-Pac Trial For Locally Advanced Pancreatic Cancer